Whether 340B drug pricing lowers your out-of-pocket cost depends on where you get care: at a Ryan White HIV clinic or a community health center, the savings often reach you through sliding-scale pricing that can bring your cost close to nothing; at most hospitals, they usually don’t. This SunnyPharma guide explains what the 340B program is, who qualifies, how to tell whether your clinic passes the savings on, and how to find one that does.
The 340B program is one of the most powerful — and most misunderstood — tools for lowering medication costs in the United States. The confusion is understandable: 340B produces enormous discounts, but those discounts flow to healthcare organizations, not directly to patients at the pharmacy counter. Understanding that distinction is the difference between assuming you’re stuck with a retail price and finding a clinic that can cut it dramatically.
Does 340B Actually Reach You? Start Here
This is the question that matters most, so it comes first. The honest answer has two branches:
If you get care at a grant-funded safety-net provider — a Ryan White HIV clinic, a federally qualified health center (FQHC), or an FQHC “look-alike” — 340B savings frequently do reach you. These organizations operate under federal grant rules that require sliding-fee discounts for low-income patients, so the money the clinic saves on 340B-priced drugs helps fund care that costs you little or nothing. For many uninsured and underinsured patients at these clinics, medications that would cost thousands at retail come to $0 or a small sliding-scale amount.
If you get care at a hospital, the picture is different. There is no general federal requirement that a hospital pass its 340B savings on to you at the pharmacy counter. Hospitals may use 340B savings to fund charity care, expand services, or offset other costs — all permitted uses — but your individual out-of-pocket cost for a given prescription may be unchanged. Some hospitals do offer generous financial assistance funded partly by 340B; others don’t. You have to ask.
The single most useful question you can ask any clinic or hospital: “Do you participate in 340B, and do you pass those savings on to patients like me?” The answer tells you whether this pathway will actually lower your cost.
What the 340B Drug Pricing Program Is
The 340B Drug Pricing Program was created by Congress in 1992 under Section 340B of the Public Health Service Act (42 U.S.C. § 256b). It requires drug manufacturers that participate in Medicaid to sell covered outpatient drugs to eligible healthcare organizations at or below a discounted “ceiling price.”
Crucially, the program uses no federal funding. Manufacturers accept the 340B discounts as a condition of having their drugs covered by Medicaid and Medicare Part B — it’s a trade, not a subsidy. The program is administered by the Health Resources and Services Administration (HRSA) through its Office of Pharmacy Affairs.
The purpose, in Congress’s words, is to let safety-net providers “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” As of April 2026, the program spanned 15,249 covered entities and reached roughly $100 billion in purchases at discounted 340B pricing.
How the Discount Actually Works
The mechanism is a spread. A covered entity buys a drug at the 340B ceiling price — often a substantial reduction off the wholesale cost — but is typically reimbursed by insurers as if it had paid a higher price. The difference is the “340B savings” that the entity keeps to fund its mission.
The 340B ceiling price itself is set by a statutory formula: a drug’s average manufacturer price minus a rebate percentage, calculated and monitored by HRSA. The exact discount varies drug by drug, and — this is the recurring theme — the savings are realized by the covered entity, not automatically handed to the patient.
- 340B is not a discount card. You can’t sign up for it or present it at a pharmacy — it works through your clinic.
- 340B savings go to the provider first. Whether they reach you depends on the provider’s type and policies.
- 340B is not the same as manufacturer assistance. Copay cards and patient assistance programs are separate tools that apply to your prescription directly.
Who Qualifies: 340B Covered Entities
Only “covered entities” can buy at 340B prices, and only their patients can benefit. Federal law defines these narrowly. The non-hospital categories most relevant to medication access include:
- Federally Qualified Health Centers (FQHCs) and FQHC look-alikes — community health centers serving underserved areas
- Ryan White HIV/AIDS Program clinics — grantees providing HIV care
- State AIDS Drug Assistance Programs (ADAPs)
- Hemophilia treatment centers
- Title X family-planning clinics
- STD and tuberculosis clinics, black-lung clinics, and Urban Indian and Native Hawaiian health organizations
In addition, six categories of hospitals qualify: disproportionate share hospitals, children’s hospitals, free-standing cancer hospitals, sole community hospitals, rural referral centers, and critical access hospitals.
Every covered entity must register in HRSA’s system, receive a 340B identification number, and recertify its eligibility every year. You can verify any organization’s status in HRSA’s public database.
The “patient” definition matters. To receive a 340B drug, you must genuinely be a patient of the covered entity — meaning the entity maintains your health records and is responsible for your care. Simply filling a prescription at a pharmacy connected to a covered entity does not, by itself, make you its patient for 340B purposes.
You Can’t Just Ask a Pharmacy for the 340B Price
This is the most common and costly misunderstanding, so it’s worth stating plainly: there is no public “340B pharmacy” where you can walk in and request the discounted price. 340B pricing is tied to your relationship with a covered entity — not to any pharmacy chain or location.
Covered entities dispense 340B drugs in one of two ways: through an in-house pharmacy, or through “contract pharmacy” arrangements with outside pharmacies that fill prescriptions on the entity’s behalf. Either way, the discount flows from your status as the entity’s patient, not from the pharmacy counter you happen to stand at.
So the real path is always the same: find a covered entity, become an established patient there, and then ask which pharmacy fills its 340B prescriptions and whether the savings reach you.
How to Find a 340B Clinic Near You
There are two practical routes, and for HIV care the second is usually faster:
- Search HRSA’s 340B database directly. The 340B OPAIS covered-entity search is public and requires no login. You can search by location to see registered entities and their contract pharmacies.
- Find an HIV clinic first, then ask about 340B. Use the HRSA Find HIV Care locator or the Ryan White HIV/AIDS Program services tool to find a Ryan White clinic near you. Most are covered entities, and their staff can tell you directly how their pharmacy arrangement works.
Once you’ve identified a nearby covered entity, the last step is a conversation: become a patient, then ask whether they pass 340B savings to patients and how their pharmacy fills prescriptions.
340B vs. Copay Cards and Patient Assistance
Patients often ask which is better: 340B or a manufacturer program. They’re different tools, and for many people they work together rather than as either/or.
| Feature | 340B Pricing | Copay Card / PAP |
|---|---|---|
| Who the benefit goes to | The clinic (may pass to you) | You, directly |
| How you access it | Be a patient of a covered entity | Enroll with the manufacturer |
| Predictable for the patient? | Depends on provider policy | Yes — applied to your prescription |
| Works with government insurance? | Yes | Copay cards: no; PAPs: often yes |
| Best when | You use a Ryan White clinic or FQHC | You have commercial insurance or are uninsured |
For most commercially insured patients, a manufacturer copay card gives a more predictable result than relying on 340B. At a Ryan White clinic, the two can combine.
What’s Changing in 2027: The Rebate Model Pilot
The way 340B discounts are delivered is facing its biggest proposed change in the program’s history — though for now the change is narrow.
On August 3, 2026, HRSA published a revised 340B Rebate Model Pilot Program, scheduled to take effect January 1, 2027. Under it, participating manufacturers would provide the 340B price as a rebate paid after the fact — the clinic buys at full wholesale cost, dispenses the drug, then claims the difference back — rather than as an upfront discount.
Three things keep this limited for now:
- It applies only to a small set of drugs tied to the Medicare Drug Price Negotiation Program for 2026 and 2027 — not to the whole 340B catalog.
- It is voluntary and requires HRSA approval for each participating manufacturer.
- It remains contested: an earlier version was vacated by a federal court in early 2026 on procedural grounds, and hospital and provider groups continue to challenge the revised pilot.
For all other drugs, upfront discounts remain the rule. If you’re a patient, this pilot does not change how you access 340B today — but it’s worth knowing the program is in active flux, because provider groups warn that a rebate model could strain the safety-net clinics many patients depend on.
What to Do Today
- Identify whether your current provider is a 340B covered entity — ask them directly, or search 340B OPAIS
- Ask the key question: “Do you pass 340B savings on to patients like me?”
- If you need HIV care, find a Ryan White clinic at findhivcare.hrsa.gov
- Locate your state ADAP through the NASTAD directory
- At a covered entity, ask which pharmacy fills its 340B prescriptions
- Don’t rely on 340B alone — pair it with copay cards or patient assistance where you can
- Never stop or delay medication over cost without talking to your clinician first
Frequently Asked Questions
What is the 340B Drug Pricing Program in simple terms?
340B is a federal program that requires drug manufacturers to sell outpatient medications at steep discounts to eligible safety-net health providers, such as Ryan White HIV clinics, community health centers, and certain hospitals. It uses no taxpayer money — manufacturers accept the discounts as a condition of having their drugs covered by Medicaid and Medicare Part B.
Does 340B lower what I personally pay for my medication?
It depends where you receive care. At grant-funded providers like Ryan White HIV clinics and federally qualified health centers, 340B savings often reach you through sliding-scale pricing that lowers or eliminates your cost. At many hospitals, there is no federal requirement to pass 340B savings to you at the pharmacy counter, so your out-of-pocket cost may not change. Ask your provider directly whether they pass 340B savings to patients.
Who qualifies to use 340B pricing?
340B pricing is available only to patients of registered covered entities — not to the general public. Covered entities include federally qualified health centers, Ryan White HIV/AIDS clinics, state AIDS Drug Assistance Programs, hemophilia treatment centers, Title X family-planning clinics, and six categories of hospitals such as disproportionate share and critical access hospitals. You must be an established patient of one of these organizations.
Can I just ask a pharmacy for the 340B price?
No. There is no public 340B pharmacy where you can walk in and request the discounted price. 340B pricing is tied to your relationship with a covered entity, not to a pharmacy chain. The real path is to become a patient of a covered entity, then ask which in-house or contract pharmacy fills its 340B-priced prescriptions.
How do I find a 340B clinic near me?
Search HRSA’s public 340B OPAIS database by location to see registered covered entities, or use the HRSA Find HIV Care locator to find a Ryan White clinic near you. Once you identify a nearby covered entity — an HIV clinic, community health center, or qualifying hospital — become a patient there and ask about its pharmacy arrangement and whether it passes 340B savings to patients.
What is a 340B covered entity?
A covered entity is a healthcare organization that HRSA has approved to purchase drugs at 340B prices. There are eleven non-hospital categories — including federally qualified health centers, Ryan White clinics, and state ADAPs — plus six hospital categories. Each must register in HRSA’s system, receive a 340B ID number, and recertify its eligibility every year.
How is 340B different from a manufacturer copay card or patient assistance program?
A 340B discount goes to the clinic that buys the drug, and only reaches you if that clinic passes the savings along. A manufacturer copay card or patient assistance program is applied directly to your prescription regardless of where you get care. For most insured patients, a copay card produces a more predictable out-of-pocket result than relying on 340B. The two can also work together at a 340B clinic.
How much does 340B discount a drug’s price?
The 340B price is a statutory ceiling calculated from a drug’s average manufacturer price minus a rebate percentage, and it commonly represents a substantial reduction off wholesale cost. The exact discount varies by drug, and the savings are realized by the covered entity, not automatically by the patient. HRSA sets and monitors these ceiling prices.
Is the 340B program changing in 2027?
A change is scheduled but limited. On August 3, 2026, HRSA published a revised 340B Rebate Model Pilot Program, effective January 1, 2027, under which participating manufacturers provide the 340B price as a rebate after the fact rather than as an upfront discount — but only for a small set of drugs tied to Medicare price negotiation, and only with HRSA approval. Upfront discounts remain the rule for all other drugs, and the pilot remains contested in court.
Does 340B apply to HIV medications like Biktarvy?
Yes. HIV antiretrovirals are among the medications covered by 340B when dispensed through an eligible covered entity such as a Ryan White clinic. If you receive HIV care at a 340B facility, your medications may cost far less than at retail. To see how this fits with copay cards, ADAP, and manufacturer assistance for a specific drug, see our Biktarvy cost guide.
- Biktarvy cost — what patients actually pay, and every $0 pathway
- HIV medication access — screener for coverage and cost support
How we reviewed this article:
SunnyPharma follows strict sourcing guidelines and relies on federal statute, government agencies (HRSA, HHS), the Federal Register, and primary program sources. We use only credible, verifiable sources to ensure accuracy.
Read our editorial policy →Sources & References
- Section 340B of the Public Health Service Act (42 U.S.C. § 256b): govinfo.gov
- HRSA Office of Pharmacy Affairs — 340B Drug Pricing Program: hrsa.gov/opa
- HRSA — 340B Eligibility and Registration: hrsa.gov
- 340B OPAIS Covered Entity Search: 340bopais.hrsa.gov
- HRSA — Notice Regarding 340B Rebate Model Pilot Program (Federal Register, Aug 3, 2026): federalregister.gov
- Ryan White HIV/AIDS Program — Available Care and Services: ryanwhite.hrsa.gov
- HRSA — Find HIV Care Locator: findhivcare.hrsa.gov
- NASTAD ADAP Directory: nastad.org